🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B cell mediated...
Status
Recruiting
Location
Children's Hospital, Zhejiang University School of Medicine
Start Date
2025-12-01
Trial ID
NCT07305116
Treatments Being Tested
The purpose of this study is to assess long-term side effects from subjects...
Status
Active Not Recruiting
Location
Blood and Marrow Transplant Program
Start Date
2022-02-14
Trial ID
NCT04911478
Treatments Being Tested
This is a first-in-human, single-arm, open-label study evaluating the safet...
Status
Recruiting
Location
Mayo Clinic
Start Date
2025-11-13
Trial ID
NCT07085104
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficiency of autol...
Status
Active Not Recruiting
Location
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Start Date
2020-07-27
Trial ID
NCT04499573
Treatments Being Tested
To observe the efficacy and safety of CD7-targeted chimeric antigen recepto...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2025-08-18
Trial ID
NCT07280494
Treatments Being Tested
Therapy with chimeric antigen receptor T (CAR-T) cells has demonstrated act...
Status
Not Yet Recruiting
Location
Taussig Cancer Institute | Cleveland Clinic
Start Date
2026-09
Trial ID
NCT07679919
Treatments Being Tested
This phase I trial investigates the side effects and best dose of CD19 posi...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2020-06-26
Trial ID
NCT03579888
Treatments Being Tested
This will be a Phase 1, open-label study to evaluate the safety and efficac...
Status
Recruiting
Location
Children's Hospital of Philadelphia
Start Date
2025-04-29
Trial ID
NCT06934382
Treatments Being Tested
Phase 1 Open-Label Dose-Escalation and Expansion Study to Assess the Safety...
Status
Not Yet Recruiting
Location
St. Vincent's Hospital
Start Date
2026-08-20
Trial ID
NCT07518329
Treatments Being Tested
ATHENA chimeric antigen receptor (CAR)-T, a CD19-directed CAR-T cell immuno...
Status
Recruiting
Location
Biotherapeutic Department, Chinese PLA General Hospital
Start Date
2023-09-06
Trial ID
NCT06014073